Plus, an unexpected beneficiary of a dead deal, a post-AI-selloff dip-buying opportunity, and a high-upside-potential call from an analyst with an average return of more than 80%.
Feb 28, 2026
Oct 10, 2026
•
1 min read
Plus, a new Alzheimer's play with a brain-shuttle edge...
Oct 3, 2026
Plus, a vaccine maker weeks from its pivotal test....
Oct 1, 2026
One stock pick from a top-ranked analyst with an implied upside of 100% or more.